Login to Your Account

Biotech IPOs Reward Investors Keeping Window Wide Open

Monday, October 7, 2013

Not only has the window for biotech initial public offerings (IPOs) remained wide open so far this year, but also the after-market performance of the newly minted public companies has been nothing short of amazing – recording a collective 68 percent increase in share price after hitting the markets. Not surprising then that companies on the biotech IPO runway have been anxious to take flight.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription